-
1
-
-
84863092194
-
European guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)
-
J. Perk, G. De Backer, H. Gohlke, I. Graham, Z. Reiner, and W.M. Verschuren et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) Atherosclerosis 223 2012 1 68
-
(2012)
Atherosclerosis
, vol.223
, pp. 1-68
-
-
Perk, J.1
De Backer, G.2
Gohlke, H.3
Graham, I.4
Reiner, Z.5
Verschuren, W.M.6
-
2
-
-
79960205374
-
The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
-
ESC/EAS Guidelines for the management of dyslipidaemias
-
A.L. Catapano, Z. Reiner, G. De Backer, I. Graham, M.R. Taskinen, O. Wiklund ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) Atherosclerosis 217 2011 3 46
-
(2011)
Atherosclerosis
, vol.217
, pp. 3-46
-
-
Catapano, A.L.1
Reiner, Z.2
De Backer, G.3
Graham, I.4
Taskinen, M.R.5
Wiklund, O.6
-
3
-
-
41549118416
-
Lipoprotein management in patients with cardiometabolic risk: Consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation
-
J.D. Brunzell, M. Davidson, C.D. Furberg, R.B. Goldberg, B.V. Howard, and J.H. Stein et al. Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation J Am Coll Cardiol 51 2008 1512 1524
-
(2008)
J Am Coll Cardiol
, vol.51
, pp. 1512-1524
-
-
Brunzell, J.D.1
Davidson, M.2
Furberg, C.D.3
Goldberg, R.B.4
Howard, B.V.5
Stein, J.H.6
-
4
-
-
77953870172
-
Riesgo vascular residual: Recomendaciones de la Iniciativa Española para la Reducción del Riesgo Residual
-
J. Millán Núñez-Cortés, J. Pedro-Botet Montoya, and X. Pintó Sala Riesgo vascular residual: recomendaciones de la Iniciativa Española para la Reducción del Riesgo Residual Med Clin (Barc) 135 2010 165 171
-
(2010)
Med Clin (Barc)
, vol.135
, pp. 165-171
-
-
Millán Núñez-Cortés, J.1
Pedro-Botet Montoya, J.2
Pintó Sala, X.3
-
7
-
-
0345600187
-
Updating the Beers criteria for potentially inappropriate medication use in older adults
-
D.M. Fick, J.W. Cooper, W.E. Wade, J.L. Waller, J.R. Maclean, and M.H. Beers Updating the Beers criteria for potentially inappropriate medication use in older adults Results of a US consensus panel of experts. Arch Intern Med 163 2003 2716 2724
-
(2003)
Results of A US Consensus Panel of Experts. Arch Intern Med
, vol.163
, pp. 2716-2724
-
-
Fick, D.M.1
Cooper, J.W.2
Wade, W.E.3
Waller, J.L.4
MacLean, J.R.5
Beers, M.H.6
-
9
-
-
85045797561
-
Literature searching for clinical and cost-effectiveness studies used in health technology assessment reports carried out for the National Institute for Clinical Excellence appraisal system
-
P. Royle, and N. Waugh Literature searching for clinical and cost-effectiveness studies used in health technology assessment reports carried out for the National Institute for Clinical Excellence appraisal system Health Technol Assess 7 2003 1 51
-
(2003)
Health Technol Assess
, vol.7
, pp. 1-51
-
-
Royle, P.1
Waugh, N.2
-
10
-
-
0001345835
-
Snowball sampling
-
L.A. Goodman Snowball sampling Ann Math Stat 32 1961 148 170
-
(1961)
Ann Math Stat
, vol.32
, pp. 148-170
-
-
Goodman, L.A.1
-
11
-
-
38749140256
-
An exploration of the use of simple statistics to measure consensus and stability in Delphi studies
-
E.A. Holey, J.L. Feeley, J. Dixon, and V.J. Whittaker An exploration of the use of simple statistics to measure consensus and stability in Delphi studies BMC Med Res Methodol 7 2007 52
-
(2007)
BMC Med Res Methodol
, vol.7
, pp. 52
-
-
Holey, E.A.1
Feeley, J.L.2
Dixon, J.3
Whittaker, V.J.4
-
12
-
-
79958148945
-
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: Evidence and guidance for management
-
M.J. Chapman, H.N. Ginsberg, P. Amarenco, F. Andreotti, J. Borén, and A.L. Catapano et al. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management Eur Heart J 32 2011 1345 1361
-
(2011)
Eur Heart J
, vol.32
, pp. 1345-1361
-
-
Chapman, M.J.1
Ginsberg, H.N.2
Amarenco, P.3
Andreotti, F.4
Borén, J.5
Catapano, A.L.6
-
13
-
-
0026065576
-
Plasma triglyceride and coronary heart disease
-
M.A. Austin Plasma triglyceride and coronary heart disease Arterioscler Thromb 11 1991 2 14
-
(1991)
Arterioscler Thromb
, vol.11
, pp. 2-14
-
-
Austin, M.A.1
-
14
-
-
0029838433
-
Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: A meta-analysis of population-based prospective studies
-
J.E. Hokanson, and M.A. Austin Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies J Cardiovasc Risk 3 1996 213 219
-
(1996)
J Cardiovasc Risk
, vol.3
, pp. 213-219
-
-
Hokanson, J.E.1
Austin, M.A.2
-
15
-
-
56149115017
-
Nonfasting triglycerides and risk of ischemic stroke in the general population
-
J.J. Freiber, A. Tybjaerg-Hansen, J.S. Jensen, and B.G. Nordestgard Nonfasting triglycerides and risk of ischemic stroke in the general population JAMA 300 2008 2142 2152
-
(2008)
JAMA
, vol.300
, pp. 2142-2152
-
-
Freiber, J.J.1
Tybjaerg-Hansen, A.2
Jensen, J.S.3
Nordestgard, B.G.4
-
16
-
-
0024501678
-
High-density lipoprotein cholesterol and cardiovascular disease
-
D.J. Gordon, J.L. Probsfield, R.J. Garrison, J.D. Neaton, W.P. Castelli, and J.D. Knoke et al. High-density lipoprotein cholesterol and cardiovascular disease Four prospective American studies. Circulation 79 1989 8 15
-
(1989)
Four Prospective American Studies. Circulation
, vol.79
, pp. 8-15
-
-
Gordon, D.J.1
Probsfield, J.L.2
Garrison, R.J.3
Neaton, J.D.4
Castelli, W.P.5
Knoke, J.D.6
-
17
-
-
70450081001
-
Major lipids, apolipoproteins, and risk of vascular disease
-
The Emerging Risk Factor Collaboration
-
The Emerging Risk Factor Collaboration Major lipids, apolipoproteins, and risk of vascular disease JAMA 302 2009 1993 2000
-
(2009)
JAMA
, vol.302
, pp. 1993-2000
-
-
-
18
-
-
34748887666
-
HDL cholesterol, very low levels of LDL cholesterol and cardiovascular events
-
Treating to New targets Investigators
-
P. Barter, A.M. Gotto, J.C. LaRosa, J. Maroni, M. Szarek, S.M. Grundy Treating to New targets Investigators HDL cholesterol, very low levels of LDL cholesterol and cardiovascular events N Engl J Med 357 2007 1301 1310
-
(2007)
N Engl J Med
, vol.357
, pp. 1301-1310
-
-
Barter, P.1
Gotto, A.M.2
Larosa, J.C.3
Maroni, J.4
Szarek, M.5
Grundy, S.M.6
-
19
-
-
78449281377
-
Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170 000 participants in 26 randomized trials
-
Cholesterol Treatment Trialist's CTT Collaboration
-
Cholesterol Treatment Trialist's CTT Collaboration Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomized trials Lancet 376 2010 1670 1681
-
(2010)
Lancet
, vol.376
, pp. 1670-1681
-
-
-
20
-
-
33750897238
-
Simultaneous low-density lipoprotein-C lowering and high-density lipoprotein-C elevation for optimum cardiovascular disease prevention with various drug subclasses, and their combinations: A meta-analysis of 23 ramdomized lipid trials
-
B.G. Brown, K.H. Stukowsky, and X.Q. Zhao Simultaneous low-density lipoprotein-C lowering and high-density lipoprotein-C elevation for optimum cardiovascular disease prevention with various drug subclasses, and their combinations: a meta-analysis of 23 ramdomized lipid trials Curr Opin Lipidol 17 2006 631 636
-
(2006)
Curr Opin Lipidol
, vol.17
, pp. 631-636
-
-
Brown, B.G.1
Stukowsky, K.H.2
Zhao, X.Q.3
-
21
-
-
85048354213
-
Combination lipid therapy in type 2 diabetes
-
F.M. Sacks, V.J. Carey, and J.C. Fruchart Combination lipid therapy in type 2 diabetes N Engl J Med 363 2010 692 694
-
(2010)
N Engl J Med
, vol.363
, pp. 692-694
-
-
Sacks, F.M.1
Carey, V.J.2
Fruchart, J.C.3
-
22
-
-
64749095070
-
Effects of fenofibrate treatment on cardiovascular disease risk in 9,795 individuals with type 2 diabetes and various components of the metabolic syndrome: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
-
Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study Investigators
-
R. Scott, R. O'Brien, G. Fulcher, C. Pardy, M. D'Emden, D. Tse Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study Investigators Effects of fenofibrate treatment on cardiovascular disease risk in 9,795 individuals with type 2 diabetes and various components of the metabolic syndrome: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study Diabetes Care 32 2009 493 498
-
(2009)
Diabetes Care
, vol.32
, pp. 493-498
-
-
Scott, R.1
O'Brien, R.2
Fulcher, G.3
Pardy, C.4
D'Emden, M.5
Tse, D.6
-
23
-
-
77951704587
-
Effects of combination lipid therapy in type 2 diabetes mellitus
-
ACCORD Study Group
-
H.N. Ginsberg, M.B. Elam, L.C. Lovato, J.R. Crouse, L.A. Leiter, P. Linz ACCORD Study Group Effects of combination lipid therapy in type 2 diabetes mellitus N Engl J Med 362 2010 1563 1574
-
(2010)
N Engl J Med
, vol.362
, pp. 1563-1574
-
-
Ginsberg, H.N.1
Elam, M.B.2
Lovato, L.C.3
Crouse, J.R.4
Leiter, L.A.5
Linz, P.6
-
24
-
-
66349137054
-
The metabolism and anti-atherogenic properties of HDL
-
K.A. Rye, C.A. Bursill, G. Lambert, F. Taber, and P.J. Barter The metabolism and anti-atherogenic properties of HDL J Lipid Res Suppl 50 2009 S195 S200
-
(2009)
J Lipid Res
, vol.50 SUPPL
-
-
Rye, K.A.1
Bursill, C.A.2
Lambert, G.3
Taber, F.4
Barter, P.J.5
|